| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 06/17/2004 | US20040115837 Characterizing in vitro transfer of drug from non-aqueous liquid composition to aqueous medium; monitoring drug diffusion from sustained release dosage |
| 06/17/2004 | US20040115743 Test kit for intracellular introduction of protein and/or peptide and method of intracellular introduction |
| 06/17/2004 | US20040115433 Mixture of hydrophobic polymer core and nanoparticles; immobilization |
| 06/17/2004 | US20040115331 Suitable for inclusion in food |
| 06/17/2004 | US20040115282 May be administered for preparing the colon for surgical or diagnostic procedures or childbirth |
| 06/17/2004 | US20040115277 Microparticles with an improved release profile and method for the production thereof |
| 06/17/2004 | US20040115276 Liquid pharmaceutical for oral delivery |
| 06/17/2004 | US20040115269 Pressure induced swelling in microporous materials |
| 06/17/2004 | US20040115264 Bioavailability |
| 06/17/2004 | US20040115262 Formulations and dosage forms for controlled delivery of topiramate |
| 06/17/2004 | US20040115261 Controlled delivery of tetracycline compounds and tetracycline derivatives |
| 06/17/2004 | US20040115260 cefquinome and a prolonged release vehicle characterised in that the prolonged release vehicle comprises a mixture of an oil and aluminium distearate |
| 06/17/2004 | US20040115258 cyclodextrin can be effective to mask the taste of pharmaceutically active agents without the formulation of inclusion complexes between the cyclodextrin and the active agent |
| 06/17/2004 | US20040115255 Method and composition for solubilising a biologically active compound with low water solubility |
| 06/17/2004 | US20040115243 Compositions for oral delivery of nutrients and pharmaceuticals |
| 06/17/2004 | US20040115239 implant with functional layer comprises particles having a structure substituted with a functional group, wherein the functional group is adapted to modify a property of the device making it more biocompatible |
| 06/17/2004 | US20040115233 Composition for improving skin environment and clothes thereof |
| 06/17/2004 | US20040115228 comprising a viscosity enhancer polymer Aculyn 44 (TM) |
| 06/17/2004 | US20040115227 Thermoformable solid pharmaceutical composition for controlled release of perindopril |
| 06/17/2004 | US20040115209 toxic or protective agent; covalently bound to a biologically active molecule adapted to selectively bind the target cell through a breakable linker |
| 06/17/2004 | US20040115207 targeting agent conjugated to a diagnostically or therapeutically effective agent by a metabolizable linker moiety, which is cleaved by an exogenous enzyme; targeting agent may be an antibody and the agent may be a radioisotope |
| 06/17/2004 | US20040115205 Use of antibodies against the MUC18 antigen |
| 06/17/2004 | US20040115202 monospecific antibody which specifically binds an epitope of a mammalian DPPIV (dipeptidyl peptidase IV, also known as CD26). |
| 06/17/2004 | US20040115192 a site-specific targeting ligand; a lipid encapsulated oil in water emulsion; and a bioactive agent in or on the surface of the outer monolayer of the emulsion; the ligand being conjugated directly or indirectly to the emulsion |
| 06/17/2004 | US20040115186 a urease enzyme, and having associated with it a chemical entity effective to enhance the delivery of the enzyme to cancer cells |
| 06/17/2004 | US20040115184 Methods and compositions for modifying apolipoprotein b mrna editing |
| 06/17/2004 | US20040115183 Site-specific in situ generation of allicin using a targeted alliinase delivery system for the treatment of cancers, tumors, infectious diseases and other allicin-senstive diseases |
| 06/17/2004 | US20040115180 Carrier chimeric proteins targeted carrier chimeric proteins and preparation thereof |
| 06/17/2004 | US20040115165 for the pegylation of therapeutically active proteins |
| 06/17/2004 | US20040115149 crosslinked copolymers of acryloyldimethyltaurine |
| 06/17/2004 | US20040115148 crosslinked copolymers of acryloyldimethyltaurine |
| 06/17/2004 | US20040112719 Extendable belt conveyor |
| 06/17/2004 | DE20220901U1 Film coating composition for controlled release of active ingredient e.g. metoprolol, comprises an acrylic polymer dispersion, a surfactant, sodium stearyl fumarate and a water-containing liquid |
| 06/17/2004 | CA2791165A1 A conjugate comprising cholesterol linked to tetracycline |
| 06/17/2004 | CA2508580A1 Methods of therapy and diagnosis using targeting of cells that express ly-9 |
| 06/17/2004 | CA2508536A1 An exopolysaccharides delivery system for active molecules |
| 06/17/2004 | CA2508519A1 Recombinant immunotoxin and use in treating tumors |
| 06/17/2004 | CA2508301A1 Low viscosity liquid dosage forms |
| 06/17/2004 | CA2507848A1 Ifosfamide compositions for parenteral administration and a process for their preparation |
| 06/17/2004 | CA2507815A1 High enantiomeric purity dexanabinol for pharmaceutical compositions |
| 06/17/2004 | CA2507769A1 Density-controlled particulate suspensions for foodstuff, cosmetic, pharmaceutical and other uses |
| 06/17/2004 | CA2507244A1 Methods of measuring the dissolution rate of an analyte in a non-aqueous liquid composition |
| 06/17/2004 | CA2505106A1 Concentrated liquid valdecoxib composition |
| 06/17/2004 | CA2504801A1 Pharmaceutical compositions of cell lysate and processes for the production and use thereof |
| 06/17/2004 | CA2504799A1 Aldonic acid esters, methods for producing the same, and methods for producing pharmaceutical active ingredients coupled to polysaccharides or polysaccharide derivatives on free amino groups |
| 06/17/2004 | CA2503973A1 Material compositions and related systems and methods for treating cardiac conditions |
| 06/17/2004 | CA2469724A1 Mutant glycoproteins |
| 06/16/2004 | EP1428537A1 Stabilized preparations containing antibody |
| 06/16/2004 | EP1428527A1 Novel formulations for transdermal delivery of pergolide |
| 06/16/2004 | EP1428525A1 Pharmaceutical preparations for the veterinary use containing acetylsalicylic acid in the form of buffered soluble powder |
| 06/16/2004 | EP1427837A2 Modular transfection systems |
| 06/16/2004 | EP1427811A1 Erythrocytic cells and method for preserving cells |
| 06/16/2004 | EP1427806A2 Polynucleotides encoding antigenic hiv type b polypeptides, polypeptides and uses thereof |
| 06/16/2004 | EP1427758A2 Compositions and methods of treating diabetes |
| 06/16/2004 | EP1427750A1 Modified transferrin fusion proteins |
| 06/16/2004 | EP1427717A1 Bioprecursors for percutaneous application |
| 06/16/2004 | EP1427712A2 Dye-azide compounds for dual phototherapy |
| 06/16/2004 | EP1427482A2 Method and apparatus for acne treatment |
| 06/16/2004 | EP1427449A1 Anti-cancer agents comprising disintegrin genes and the treating methods |
| 06/16/2004 | EP1427448A1 Aqueous air foam |
| 06/16/2004 | EP1427447A1 Improved therapeutic protocols |
| 06/16/2004 | EP1427446A2 The use of effect pigments in ingested drugs |
| 06/16/2004 | EP1427441A2 Composite superimmunogen for bi-functional vaccine use for the treatment of illnesses associated with a stromal tissue disorder |
| 06/16/2004 | EP1427436A2 Use of milk serum apoproteins in the prophylaxis or treatment of microbial or viral infection |
| 06/16/2004 | EP1427433A1 Biodegradable implant comprising a polylactide polymer and a lh-rh analogue |
| 06/16/2004 | EP1427431A2 Bioadhesive compositions and methods for enhanced mucosal drug absorption |
| 06/16/2004 | EP1427427A1 Derivatives of partially desulphated glycosaminoglycans as heparanase inhibitors, endowed with antiangiogenic activity and devoid of anticoagulating effect |
| 06/16/2004 | EP1427419A1 Improvement of the local compatibility during intravenous administration of 4-(4-(2-pyrrolylcarbonyl)-1-piperazinyl)-3-trifluormethyl-benzoylguanidine |
| 06/16/2004 | EP1427414A1 Inhalation compositions comprising tricyclic 5,6-dihydro-9h-pyrazolo (3,4-c)-1,2,4-triazolo (4,3-alpha) pyridines |
| 06/16/2004 | EP1427400A2 Triclosan dosage form |
| 06/16/2004 | EP1427397A1 Oily thixotropic formulations |
| 06/16/2004 | EP1427396A1 Dosage forms having prolonged active ingredient release |
| 06/16/2004 | EP1427394A1 Process for accelerating recovery from trauma by using apoptosis-mimicking synthetic or natural entities |
| 06/16/2004 | EP1427392A1 New self emulsifying drug delivery system |
| 06/16/2004 | EP1427391A1 Vascular occlusion solid-phase agent with immobilised platelet binding agent |
| 06/16/2004 | EP1427390A1 Drug delivery system |
| 06/16/2004 | EP1427383A1 Compositions and methods relating to prevention of chemotherapy-induced alopecia |
| 06/16/2004 | EP1427380A1 Fluid-to-powder compositions |
| 06/16/2004 | EP1427366A2 Vaginal delivery of chemotherapeutic agents and inhibitors of membrane efflux systems for cancer therapy |
| 06/16/2004 | EP1427289A2 Pulsatile release compositions and methods for enhanced gastrointestinal drug absorption |
| 06/16/2004 | EP1380639A4 Method for producing a water-alcohol solution and products based thereon |
| 06/16/2004 | EP1294413B1 Sprayable wound care compositions |
| 06/16/2004 | EP1294364A4 Stable gabapentin having ph within a controlled range |
| 06/16/2004 | EP1265698B1 Lipid nanocapsules, preparation method and use as medicine |
| 06/16/2004 | EP1263818B1 Cosmetic agent |
| 06/16/2004 | EP1204417B1 Parenteral cisplatin emulsion |
| 06/16/2004 | EP1200096B1 Tixocortol pivalate suspension, mouth-wash based thereon and packaging containing same |
| 06/16/2004 | EP1194132B1 Timed dual release dosage forms comprising a short acting hypnotic or a salt thereof |
| 06/16/2004 | EP1187539A4 Method and composition for masking mineral taste |
| 06/16/2004 | EP1173150B1 Cosmetic and/or pharmaceutical preparations |
| 06/16/2004 | EP1165044B1 High potency dihydroergotamine compositions |
| 06/16/2004 | EP1140068B1 Doramectin formulations |
| 06/16/2004 | EP1126881B1 Muco-adhesive polymers, use thereof and method for producing the same |
| 06/16/2004 | EP1100476B1 Formulations for the transdermal administration of fenoldopam |
| 06/16/2004 | EP1100433B1 Finely dispersed emulsifier-free systems of the oil-in-water and water-in-oil type, containing boron nitride |
| 06/16/2004 | EP1098649B1 Method for stabilizing pharmaceutical compositions by special use of an antioxidant |
| 06/16/2004 | EP1082109B1 Oral formulation comprising biguanide and an organic acid |
| 06/16/2004 | EP1071466B1 Glycolipid creams |
| 06/16/2004 | EP1064942B1 Sustained release preparation of a macrolide |
| 06/16/2004 | EP1061947B1 Stabilized aqueous glucagon solutions comprising detergents |